Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Comprehensive molecular pharmacodynamic assessment identifies response markers of intermediary metabolism associated with BPM 31510-IV treatment in advanced glioblastoma multiforme patients. Nagpal, S., Sarangarajan, R., Bruce, C., Miller, G. M., Rodrigues, L. O., Shah, P., Searfoss, R., Ofori-Mensa, K., Tolstikov, V., Greenwood, B., Bussberg, V., Kiebish, M. A., Granger, E., Narain, N. R., Recht, L. LIPPINCOTT WILLIAMS & WILKINS. 2021
View details for DOI 10.1200/JCO.2021.39.15_suppl.2059
View details for Web of Science ID 000708120601016